Michigan Creates Monkeypox Website As CDC Says Vaccine Supply Falls Far Short Of Demand

The site, Michigan.gov/mpv, provides information about the signs and symptoms of monkeypox and how to get help, the state’s case count by county, and information for health care providers about testing and coordinating with local health departments, the MDHHS explained. in a statement Wednesday.


Information on the state’s case count will be updated regularly on the website, according to MDHHS in the statement. The United States has reported more than 2,000 cases so far, with hundreds more being added every day.

“MDHHS is working closely with our federal partners, local health departments and health care providers across the state in response to this outbreak,” Natasha Bagdasarian, MDHHS Medical Director, said in the statement. “MPV is a viral disease that is spread primarily through direct contact with infectious rashes, scabs, bodily fluids, or prolonged face-to-face contact. It is important to remember that the risk to the general public is low. However, Michiganders worried about MPV should see its supplier evaluated for testing.”

Monkeypox does not spread easily among human populations and the vaccine is at least 85% effective against the virus, according to studies from the US Centers for Disease Control and Prevention. The CDC said the United States has two licensed vaccines to prevent monkeypox infections: JYNNEOS (also known as Imvamune or Imvanex) and ACAM2000.

In the United States, supply of JYNNEOS is currently limited, although other vaccines are expected in the coming weeks and months. There is a sufficient supply of ACAM2000. But, this vaccine should not be used in people who have certain health conditions, including a weakened immune system, skin conditions like atopic dermatitis/eczema, or pregnancy, according to the CDC.

JYNNEOS is available now for people at high risk of exposure: those who have been identified as close contacts of someone diagnosed with monkeypox, those who have had sex with a partner in who have been diagnosed with monkeypox in the past 14 days and those who have had multiple sexual partners in the past 14 days in an area where monkeypox has spread, according to the CDC.

Decisions on how to allocate the limited vaccine supply are based equally on the number of cases and the population at risk in a specific area. As more vaccines become available, the CDC will continue to evaluate the distribution strategy, an agency spokesperson told CNN.

States receive allocations of vaccines from the strategic national stockpile based on the number of monkeypox cases and the size of the underlying at-risk population, according to MDHHS in the release. Michigan received a limited supply from JYNNEOS. Additional limited allocations will follow in the coming months, but specific quantities and timelines are not yet known.

“Healthcare providers should be alert to any rash with typical features of monkeypox,” Dr. Inger Damon, director of the CDC’s Division of Pathogens and High Consequence Conditions, said in a statement. “We ask the public to contact their health care provider if they have a new rash and are concerned about monkeypox.”

Monkeypox is a rare but potentially serious viral illness that usually begins with flu-like symptoms and swollen lymph nodes and progresses to a generalized rash on the face and body. People with symptoms should contact a health care provider for evaluation, according to MDHHS in the statement. While many of those affected by current global epidemics are men who have sex with men, anyone who has been in close contact with someone with monkeypox can contract the disease.

Monkeypox re-emerged in Nigeria in 2017 after more than 40 years with no reported cases.

Since then, more than 15,000 cases have been reported worldwide. While the United States, Britain, Canada and other countries have bought millions of vaccines, none have gone to Africa, where a more serious version of monkeypox has already killed more than 70 people. Rich countries have yet to report any deaths from monkeypox, according to the World Health Organization.

Additionally, the World Health Organization’s emergency committee met on Thursday to consider for the second time in weeks whether to declare monkeypox a global crisis.

“I remain concerned about the number of cases, in an increasing number of countries, that have been reported,” WHO Director-General Tedros Adhanom Ghebreyesus told the emergency committee as its meeting began.

For more information, visit Michigan.gov/mpv or CDC.gov/monkeypox.

Comments are closed.